InnoCare Pharma CEO Buys 100,000 Shares On Market

InnoCare Pharma (07630) said Executive Director and Chief Executive Tsai Sui-hsiung recently bought a total of 100,000 ordinary shares in the open market at an average price of about HK$14.6105 each, spending about HK$1.461 million, according to ETNet. The purchases represented about 0.035% of the company's issued share capital. After the buying, Tsai's stake in the company will rise to about 6.564%. Tsai said he is confident in the group's overall development prospects and did not rule out further share purchases.